{"id":"https://openalex.org/W4382538870","doi":"https://doi.org/10.1158/2767-9764.23600234","title":"Figure S1 from Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 Therapy in Advanced Hepatocellular Carcinoma","display_name":"Figure S1 from Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 Therapy in Advanced Hepatocellular Carcinoma","publication_year":2023,"publication_date":"2023-06-29","ids":{"openalex":"https://openalex.org/W4382538870","doi":"https://doi.org/10.1158/2767-9764.23600234"},"language":"en","primary_location":{"id":"doi:10.1158/2767-9764.23600234","doi":"https://doi.org/10.1158/2767-9764.23600234","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/2767-9764.23600234","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Figure_S1_from_Salvage_Ipilimumab_plus_Nivolumab_after_Anti-PD-1_PD-L1_Therapy_in_Advanced_Hepatocellular_Carcinoma/23600234/1/files/41401649.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Figure_S1_from_Salvage_Ipilimumab_plus_Nivolumab_after_Anti-PD-1_PD-L1_Therapy_in_Advanced_Hepatocellular_Carcinoma/23600234/1/files/41401649.pdf","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037518890","display_name":"Stephanie Leigh Alden","orcid":"https://orcid.org/0000-0003-0500-8696","observed_orcids":["https://orcid.org/0000-0003-0500-8696"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephanie L Alden","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0500-8696","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069227296","display_name":"Mir Lim","orcid":"https://orcid.org/0000-0002-6102-0887","observed_orcids":["https://orcid.org/0000-0002-6102-0887"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mir Lim","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6102-0887","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030296076","display_name":"Chester Kao","orcid":"https://orcid.org/0000-0003-2568-2071","observed_orcids":["https://orcid.org/0000-0003-2568-2071"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chester Kao","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2568-2071","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024888979","display_name":"Daniel H. Shu","orcid":"https://orcid.org/0000-0003-1348-5556","observed_orcids":["https://orcid.org/0000-0003-1348-5556"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel Shu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1348-5556","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014214683","display_name":"Amit G. Singal","orcid":"https://orcid.org/0000-0002-1172-3971","observed_orcids":["https://orcid.org/0000-0002-1172-3971"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amit G Singal","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1172-3971","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009849305","display_name":"Anne M. Noonan","orcid":"https://orcid.org/0000-0001-8083-8492","observed_orcids":["https://orcid.org/0000-0001-8083-8492"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anne Noonan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8083-8492","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069728610","display_name":"Paige Griffith","orcid":"https://orcid.org/0009-0008-9854-8950","observed_orcids":["https://orcid.org/0009-0008-9854-8950"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paige Griffith","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0008-9854-8950","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027525899","display_name":"Marina Baretti","orcid":"https://orcid.org/0000-0003-0125-2405","observed_orcids":["https://orcid.org/0000-0003-0125-2405"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marina Baretti","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0125-2405","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048843293","display_name":"Won Jin Ho","orcid":"https://orcid.org/0000-0003-2644-5086","observed_orcids":["https://orcid.org/0000-0003-2644-5086"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Won Jin Ho","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2644-5086","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067085754","display_name":"Ihab R. Kamel","orcid":"https://orcid.org/0000-0003-0511-7796","observed_orcids":["https://orcid.org/0000-0003-0511-7796"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ihab Kamel","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0511-7796","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076456783","display_name":"Mark M. Yarchoan","orcid":"https://orcid.org/0000-0003-4401-0748","observed_orcids":["https://orcid.org/0000-0003-4401-0748"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark Yarchoan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4401-0748","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5071411184","display_name":"David Hsiehchen","orcid":"https://orcid.org/0000-0001-9139-302X","observed_orcids":["https://orcid.org/0000-0001-9139-302X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Hsiehchen","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9139-302X","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.7167999744415283,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.7167999744415283,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.28029999136924744,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10340","display_name":"Hepatitis B Virus Studies","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ipilimumab","display_name":"ipilimumab","score":0.8600000143051147},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":1.0},{"id":"https://openalex.org/keywords/salvage-therapy","display_name":"salvage therapy","score":0.6230000257492065},{"id":"https://openalex.org/keywords/pd-1-pd-l1-blockade","display_name":"PD-1/PD-L1 blockade","score":0.9610000252723694},{"id":"https://openalex.org/keywords/advanced-hepatocellular-carcinoma","display_name":"advanced hepatocellular carcinoma","score":0.8949999809265137},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.640999972820282},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.8939999938011169}],"concepts":[{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.969443678855896},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.9023709297180176},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.8169093132019043},{"id":"https://openalex.org/C2781053074","wikidata":"https://www.wikidata.org/wiki/Q21100639","display_name":"PD-L1","level":4,"score":0.7127463221549988},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6166901588439941},{"id":"https://openalex.org/C2780775027","wikidata":"https://www.wikidata.org/wiki/Q17141389","display_name":"Salvage therapy","level":3,"score":0.6152133941650391},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5324685573577881},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4843934178352356},{"id":"https://openalex.org/C169382597","wikidata":"https://www.wikidata.org/wiki/Q21208025","display_name":"Programmed cell death 1","level":5,"score":0.48156026005744934},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.3634952902793884},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3524707853794098},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.13512000441551208},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.11223652958869934}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/2767-9764.23600234","doi":"https://doi.org/10.1158/2767-9764.23600234","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/2767-9764.23600234","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Figure_S1_from_Salvage_Ipilimumab_plus_Nivolumab_after_Anti-PD-1_PD-L1_Therapy_in_Advanced_Hepatocellular_Carcinoma/23600234/1/files/41401649.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/2767-9764.23600234","doi":"https://doi.org/10.1158/2767-9764.23600234","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/2767-9764.23600234","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Figure_S1_from_Salvage_Ipilimumab_plus_Nivolumab_after_Anti-PD-1_PD-L1_Therapy_in_Advanced_Hepatocellular_Carcinoma/23600234/1/files/41401649.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4382538870.pdf","grobid_xml":"https://content.openalex.org/works/W4382538870.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4384818167","https://openalex.org/W4382538971","https://openalex.org/W4384828894","https://openalex.org/W4384829097","https://openalex.org/W4384821320","https://openalex.org/W4382726175","https://openalex.org/W4384818490","https://openalex.org/W4379330250","https://openalex.org/W3122408720","https://openalex.org/W7162650024"],"abstract_inverted_index":{"Figure":[0],"S1.":[1],"Survival":[2],"Characteristics":[3],"by":[4],"Response":[5]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2023-06-30T00:00:00"}